- Filed
- Apr 28, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 3.56M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $10K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.12M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.97M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $3.99M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.17M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.09M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $9.03M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $12.69M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $12.71M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $9.09M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $8.64M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $13.93M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $11.08M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $14.05M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $14.05M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $19.67M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $20.11M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$2.04 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1.84 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$2.04 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$1.84 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $583K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $988K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.89M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.89M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$5.62M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.44M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $1.07M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $1.81M |